Significance of binary and ternary copper(II) complexes for the promotion and protection of adenosine 5′-di- and triphosphate toward hydrolysis

The dephosphorylation of ADP and ATP was characterized as the first-order rate constant in dependence on pH in the absence and presence of Cu²⁺, and together with Cu²⁺ and a second ligand. The reaction is strongly accelerated by Cu²⁺ and passes through pH optima at about 6.2 and 6.5 for the Cu²⁺ ?ADP and ?ATP systems, respectively (I = 0.1, NaClO₄; 50°C). In the presence of 2,2′-bipyridyl (Bipy), ternary complexes are formed with the nucleotides ADP or ATP (NP), Cu(Bipy)(NP), which are very stable towards dephosphorylation over a large pH range. Similar stabilizing effects were observed in ternary complexes formed with imidazole or OH^?. These results can easily be rationalized by taking into account that in the binary Cu²⁺ complexes macrochelates are formed by the interaction between the adenine moiety and the metal ion. This interaction is crucial for obtaining the labile species and hence, in the mixed-ligand complexes, where the macrophelate can not be formed, the phosphates are protected toward hydrolysis. In agreement with these results is the dephosphorylation behavior of Cu(CDP)^? and Cu(CTP)^2?; they are rather stable. This is in accord with the small coordination tendency of the cytosine moiety.By computing the pH dependence of the distribution of the several species, it is shown that the active species are Cu(ATP)^2? and Cu(ADP)^? and not the hydroxy complexes, [Cu(ATP)(OH)]₂^6? and [Cu(ADP)(OH)₂^4? as were suggested earlier. With the aid of the initial rate, $\text{ν}{}_0\text{=}\text{d}\text{[}\text{PO}{}_4{}^{\mathrm{3?}}\text{]}\text{d}\text{t}$, the rate laws of the ascending side of the pH optima were determined: $\text{ν}{}_0\text{= k}\text{[}\text{Cu(NP)}\text{]}\text{[}\text{H}{}^{\mathrm{+}}\text{]}$. The descending side of the pH optima is attributed to the formation of Cu(NP)(OH), where the metal ion interaction with N-7 of the adenine moiety is inhibited.     

Ionic channels: modulation by G proteins and by phosphorylation.

The gating of ion channels may be modulated by G proteins or by phosphorylation. Direct coupling between G proteins and ion channels has been shown in excised patches of membrane. Steps must now be taken to study the protein domains of G proteins and ion channels involved in the mutual interaction. The concept of channel modulation by protein kinases has recently been extended to include additional types of ion channel.     

Aldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma

Background

Childhood hospitalization related to asthma remains at historically high levels, and its incidence is on the rise world-wide. Previously, we have demonstrated that aldose reductase (AR), a regulatory enzyme of polyol pathway, is a major mediator of allergen-induced asthma pathogenesis in mouse models. Here, using AR null (AR^-/-) mice we have investigated the effect of AR deficiency on the pathogenesis of ragweed pollen extract (RWE)-induced allergic asthma in mice and also examined the efficacy of enteral administration of highly specific AR inhibitor, fidarestat.

Methods

The wild type (WT) and AR^-/- mice were sensitized and challenged with RWE to induce allergic asthma. AR inhibitor, fidarestat was administered orally. Airway hyper-responsiveness was measured in unrestrained animals using whole body plethysmography. Mucin levels and Th2 cytokine in broncho-alveolar lavage (BAL) were determined using mouse anti-Muc5A/C ELISA kit and multiplex cytokine array, respectively. Eosinophils infiltration and goblet cells were assessed by H&E and periodic acid Schiff (PAS)-staining of formalin-fixed, paraffin-embedded lung sections. T regulatory cells were assessed in spleen derived CD4⁺CD25⁺ T cells population.

Results

Deficiency of AR in mice led to significantly decreased PENH, a marker of airway hyper-responsiveness, metaplasia of airway epithelial cells and mucus hyper-secretion following RWE-challenge. This was accompanied by a dramatic decrease in infiltration of eosinophils into sub-epithelium of lung as well as in BAL and release of Th2 cytokines in response to RWE-challenge of AR^-/- mice. Further, enteral administration of fidarestat significantly prevented eosinophils infiltration, airway hyper-responsiveness and also markedly increased population of T regulatory (CD4⁺CD25⁺FoxP3⁺) cells as compared to RWE-sensitized and challenged mice not treated with fidarestat.

Conclusion

Our results using AR^-/- mice strongly suggest the role of AR in allergic asthma pathogenesis and effectiveness of oral administration of AR inhibitor in RWE-induced asthma in mice supports the use of AR inhibitors in the treatment of allergic asthma.     

Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines

Introduction  

Traumatic joint injury damages cartilage and causes adjacent joint tissues to release inflammatory cytokines, increasing the risk of developing osteoarthritis. The main objective of this study was to determine whether the combined catabolic effects of mechanical injury, tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)/soluble IL-6 receptor (sIL-6R) on cartilage could be abolished by short-term treatment with glucocorticoids such as dexamethasone.     

Telmisartan induces apoptosis and regulates Bcl-2 in human renal cancer cells

It has been well-characterized that the renin-angiotensin system (RAS) physiologically regulates systemic arterial pressure. However, RAS signaling has also been shown to increase cell proliferation during malignancy, and angiotensin receptor blockers (ARBs) are able to decrease pro-survival signaling by inhibiting anti-apoptotic molecules and suppressing caspase activity. In this study, the apoptotic effects of telmisartan, a type of ARB, was evaluated using a non-cancerous human renal cell line (HEK) and a human renal cell carcinoma (RCC) cell line (786). Both types of cells were treated with telmisartan for 4 h, 24 h, and 48 h, and then were assayed for levels of apoptosis, caspase-3, and Bcl-2 using MTT assays, flow cytometry, and immunostaining studies. Analysis of variance was used to identify significant differences between these data (P < 0.05). Following the treatment of 786 cells with 100 µM and 200 µM telmisartan, a marked inhibition of cell proliferation was observed. 50 µM cisplatin also caused high inhibition of these cells. Moreover, these inhibitions were both concentration- and time-dependent (P < 0.05). Various apoptotic effects were also observed compared with control cells at the 24 h and 48 h timepoints assayed (P < 0.001). Furthermore, positive caspase-3 staining and down-regulation of Bcl-2 were detected, consistent with induction of cell death. In contrast, treatment of HEK cells with telmisartan did not produce an apoptotic effect compared with control cells at the 24 h timepoint (P > 0.05). Treatment with cisplatin promoted in HEK cells high index of apoptosis (P < 0.001). Taken together, these results suggest that telmisartan induces apoptosis via down-regulation of Bcl-2 and involvement of caspase-3 in human RCC cells.